HF Sinclair
DINO
115.63
+1.03
+0.90%
HF Sinclair
US · DINO
#955 by market cap
Listed 1970
115.63
+1.03
+0.90%
Live - 5344 symbols - heartbeat 207s ago
· 2026-10-08 08:36
Pre-market
117.90
+1.96%
After-hours
115.63
0.00%
Overnight
116.34
+0.61%
- Market cap
- 20.56B
- P/E (TTM)i
- 11.02
- P/Bi
- 2.00
- EPSi
- 3.08
- Div yieldi
- 1.73%
- 52W posi
- 96%
Reader sentiment
Are you bullish or bearish on DINO?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Good
- Altman Z-Score is 4.14, above the 3.0 "safe zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year -5.99% YoY
Margins
- Gross margin
- 5.18%
- Operating margin
- 3.45%
- Net margin
- 2.14%
Key ratios & quality
- Enterprise valuei
- 22.45B
- Altman Z-Scorei
- 4.14
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 17.71B | 17.49B | 11.18B | 18.39B | 38.21B | 31.96B | 28.58B | 26.87B |
| Gross profit | 1.91B | 1.78B | 125.15M | 1.11B | 4.48B | 2.70B | 725.00M | 1.39B |
| Selling & admin expenses | 290.42M | 354.24M | 313.60M | 362.01M | 427.00M | 497.00M | 447.00M | 456.00M |
| Research & development | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating profit | 1.62B | 1.43B | -188.45M | 749.19M | 4.05B | 2.20B | 261.00M | 927.00M |
| Pretax profit | 1.52B | 1.17B | -747.05M | 787.15M | 3.94B | 2.15B | 218.00M | 732.00M |
| Tax | 347.24M | 299.15M | -232.15M | 123.90M | 895.00M | 442.00M | 34.00M | 146.00M |
| Net profit | 1.18B | 872.35M | -514.90M | 663.25M | 3.04B | 1.71B | 184.00M | 586.00M |
| Basic EPS | 6 | 5 | -4 | 3 | 14 | 8 | 1 | 3 |
| Diluted EPS | 6.19 | 4.61 | -3.72 | 3.39 | 14.28 | 8.29 | 0.91 | 3.08 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 6.37B | 6.78B | 7.25B | 6.46B | 7.12B | 10.39B |
| Gross profit | 190.00M | 398.00M | 673.00M | 131.00M | 962.00M | 1.35B |
| Selling & admin expenses | 104.00M | 114.00M | 105.00M | 133.00M | 115.00M | 130.00M |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | 81.00M | 283.00M | 564.00M | 7.00M | 847.00M | 1.22B |
| Pretax profit | -1.00M | 246.00M | 528.00M | -41.00M | 839.00M | 1.17B |
| Tax | 1.00M | 36.00M | 123.00M | -14.00M | 189.00M | 279.00M |
| Net profit | -2.00M | 210.00M | 405.00M | -27.00M | 650.00M | 893.00M |
| Basic EPS | 0 | 1 | 2 | 0 | 4 | 5 |
| Diluted EPS | -0.02 | 1.10 | 2.15 | -0.16 | 3.56 | 4.93 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 3.30B | 3.31B | 3.31B | 3.76B | 6.75B | 6.15B | 5.01B | 4.81B |
| Cash & ST investments | 1.15B | 885.16M | 1.37B | 234.44M | 1.67B | 1.35B | 800.00M | 978.00M |
| Inventory | 1.35B | 1.47B | 1.17B | 2.12B | 3.21B | 2.92B | 2.80B | 2.57B |
| Total assets | 10.99B | 12.16B | 11.51B | 12.92B | 18.13B | 17.72B | 16.64B | 16.51B |
| Total current liabilities | 1.17B | 1.69B | 1.38B | 2.07B | 3.25B | 2.78B | 3.04B | 2.49B |
| Short-term debt | -- | 104.42M | 97.94M | 110.61M | 416.89M | 118.00M | 438.00M | 99.00M |
| Long-term debt | 2.41B | 2.46B | 3.14B | 3.07B | 2.95B | 2.74B | 2.29B | 2.77B |
| Total liabilities | 4,535,542,000.00 | 5,655,415,000.00 | 5,784,661,000.00 | 6,622,148,000.00 | 8,107,911,000.00 | 7,479,000,000.00 | 7,297,000,000.00 | 7,261,000,000.00 |
| Total equity | 6.46B | 6.51B | 5.72B | 6.29B | 10.02B | 10.24B | 9.35B | 9.25B |
| Retained earnings | 4.20B | 4.74B | 3.91B | 4.41B | 4.13B | 5.38B | 5.17B | 5.37B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 4.99B | 5.17B | 5.64B | 4.81B | 6.44B | 7.39B |
| Cash & ST investments | 547.00M | 874.00M | 1.45B | 978.00M | 1.15B | 2.26B |
| Inventory | 2.98B | 2.81B | 2.78B | 2.57B | 3.27B | 3.28B |
| Total assets | 16.54B | 16.84B | 17.26B | 16.51B | 18.17B | 18.99B |
| Total current liabilities | 2.66B | 2.84B | 2.95B | 2.49B | 3.59B | 3.75B |
| Short-term debt | 89.00M | 97.00M | 99.00M | 99.00M | 107.00M | 104.00M |
| Long-term debt | 2.68B | 2.68B | 2.77B | 2.77B | 2.77B | 2.77B |
| Total liabilities | 7,289,000,000.00 | 7,495,000,000.00 | 7,769,000,000.00 | 7,261,000,000.00 | 8,443,000,000.00 | 8,644,000,000.00 |
| Total equity | 9.25B | 9.35B | 9.50B | 9.25B | 9.73B | 10.35B |
| Retained earnings | 5.07B | 5.18B | 5.49B | 5.37B | 5.93B | 6.73B |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 1.55B | 1.55B | 457.93M | 406.68M | 3.78B | 2.30B | 1.11B | 1.32B |
| Depreciation & amortization | 437.32M | 509.93M | 520.91M | 503.54M | 657.00M | 771.00M | 832.00M | 909.00M |
| Free cash flow | 1.24B | 1.25B | 127.77M | -406.73M | 3.25B | 1.91B | 640.00M | 794.00M |
| Dividends paid | -233.54M | -225.17M | -229.49M | -57.66M | -256.00M | -341.00M | -386.00M | -376.00M |
| Stock buybacks / issuance | -248.68M | -533.08M | -7.64M | -7.06M | -1.37B | -999.00M | -672.00M | -354.00M |
| Ending cash balance | 1.15B | 885.16M | 1.37B | 234.44M | 1.67B | 1.35B | 800.00M | 978.00M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | -89.00M | 587.00M | 809.00M | 8.00M | 457.00M | 1.51B |
| Depreciation & amortization | 225.00M | 226.00M | 230.00M | 228.00M | 229.00M | 228.00M |
| Free cash flow | -175.00M | 476.00M | 688.00M | -195.00M | 355.00M | 1.39B |
| Dividends paid | -95.00M | -95.00M | -94.00M | -92.00M | -91.00M | -89.00M |
| Stock buybacks / issuance | 0 | -50.00M | -166.00M | -138.00M | -76.00M | -179.00M |
| Ending cash balance | 547.00M | 874.00M | 1.45B | 978.00M | 1.15B | 2.26B |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 19.39 | 12.97 | -10.82 | 10.15 | 38.75 | 16.23 | 1.80 | 6.22 |
| ROA %i | 10.09 | 6.66 | -5.10 | 4.51 | 18.64 | 8.79 | 1.02 | 3.46 |
| ROIC %i | 14.60 | 9.94 | -5.93 | 7.31 | 27.27 | 12.65 | 1.96 | 5.76 |
| 5-year avg ROE %i | 9.72 | 11.34 | 6.44 | 9.52 | 14.09 | 13.46 | 11.22 | 14.63 |
| EBIT margin %i | 9.35 | 7.52 | -5.55 | 4.96 | 10.76 | 7.33 | 1.34 | 3.53 |
| FCF / sales %i | 7.02 | 7.18 | 1.14 | -- | 8.52 | 5.98 | 2.24 | 2.96 |
| Current ratioi | 2.82 | 1.96 | 2.41 | 1.82 | 2.08 | 2.21 | 1.65 | 1.94 |
| Quick ratioi | 1.59 | 1.05 | 1.52 | 0.76 | 1.05 | 1.13 | 0.70 | 0.87 |
| Debt / assetsi | 21.93 | 24.04 | 30.65 | 27.04 | 19.97 | 17.96 | 18.61 | 19.58 |
| LT debt / equityi | 40.75 | 47.17 | 66.34 | 59.45 | 34.65 | 30.12 | 28.67 | 34.11 |
| Interest coveragei | 12.60 | 9.17 | -4.90 | 7.29 | 23.41 | 12.28 | 2.32 | 4.37 |
| Revenue CAGR (3Y) %i | 10.20 | 18.40 | -7.76 | 1.25 | 29.76 | 41.91 | 15.83 | -11.07 |
| Net income CAGR (3Y) %i | 14.05 | -- | -- | -20.18 | 55.83 | -- | -31.81 | -41.71 |
| FCF CAGR (3Y) %i | 58.93 | 114.49 | -42.70 | -- | 37.37 | 146.43 | -- | -37.51 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | -1.47 | -0.90 | 4.08 | 6.22 | 12.95 | 19.41 |
| ROA %i | -0.83 | -0.50 | 2.27 | 3.46 | 7.03 | 10.60 |
| ROIC %i | -0.48 | 0.01 | 3.92 | 5.76 | 10.72 | 15.37 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | -0.04 | 0.23 | 2.73 | 3.53 | 6.45 | 8.56 |
| FCF / sales %i | 0.85 | 2.13 | 2.51 | 2.96 | 4.79 | 7.17 |
| Current ratioi | 1.87 | 1.82 | 1.91 | 1.94 | 1.79 | 1.97 |
| Quick ratioi | 0.72 | 0.80 | 0.95 | 0.87 | 0.85 | 1.07 |
| Debt / assetsi | 18.89 | 18.69 | 18.77 | 19.58 | 17.91 | 17.08 |
| LT debt / equityi | 33.05 | 32.87 | 33.32 | 34.11 | 32.56 | 30.53 |
| Interest coveragei | -0.07 | 0.35 | 3.84 | 4.37 | 8.52 | 15.19 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Single-engine
- Refining is the largest reported line at 88.82% of revenue, across 6 reported segments.
- The next-largest line, Marketing, is a distant second at 13.19% - a sharp slowdown here would have little to offset it.
Revenue breakdown most recent period
Business
Refining88.82%
Marketing13.19%
Lubricants & Specialties9.62%
Renewables4.68%
Midstream1.61%
Quote time 2026-10-08 08:36:47 · For reference only, not investment advice and not tailored to your situation.